Daymark Wealth Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.22M Buy
8,308
+92
+1% +$24.9K 0.07% 196
2025
Q4
$2.06M Buy
8,216
+12
+0.1% +$3.19K 0.07% 192
2025
Q3
$2.36M Buy
8,204
+206
+3% +$55.2K 0.08% 175
2025
Q2
$2.1M Buy
7,998
+22
+0.3% +$5.36K 0.08% 177
2025
Q1
$1.86M Sell
7,976
-19
-0.2% -$4.61K 0.08% 175
2024
Q4
$1.83M Buy
7,995
+61
+0.8% +$14K 0.08% 172
2024
Q3
$1.77M Sell
7,934
-9
-0.1% -$1.98K 0.08% 179
2024
Q2
$1.62M Buy
7,943
+28
+0.4% +$5.7K 0.07% 181
2024
Q1
$1.73M Hold
7,915
0.09% 142
2023
Q4
$1.8M Sell
7,915
-23
-0.3% -$4.83K 0.11% 133
2023
Q3
$1.6M Buy
7,938
+6,695
+539% +$1.41M 0.11% 134
2023
Q2
$258K Buy
+1,243
New +$241K 0.02% 317

Other funds holding LH

Daymark Wealth Partners's LH Position: Q1 2026 in Review

Daymark Wealth Partners increased its Labcorp (LH) stake by 1.1% in Q1 2026, buying an estimated $24.9K and bringing the position to 8,308 shares worth $2.22M. The position accounts for 0.07% of the portfolio, ranked #196.

Daymark Wealth Partners first reported a position in LH in Q2 2023 and has held it in 12 quarters since. The position peaked at $2.36M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Daymark Wealth Partners held 8,308 shares of Labcorp worth $2.22M as of Q1 2026.
  • Daymark Wealth Partners bought 92 Labcorp shares in Q1 2026, an estimated $24.9K.
  • Labcorp made up 0.07% of Daymark Wealth Partners's portfolio in Q1 2026, its #196 holding.
  • Daymark Wealth Partners first reported a position in Labcorp in Q2 2023 and has held it in 12 quarters since.
  • Daymark Wealth Partners's Labcorp position peaked at $2.36M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Daymark Wealth Partners's 13F filing for Q1 2026, filed 11 May 2026.